External insulin pump treatment in the day-to-day management of diabetes: Benefits and future prospectives

Diabetes and Metabolism

Volumn 37, Issue SUPPL. 4, 2011, Pages

  Hanaire, H ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Diabetes; External insulin pump; Glycaemic control; HbA 1c; Intensive insulin therapy; Review

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CATHETER; CONTINUOUS INFUSION; DIABETIC PATIENT; DISEASE SEVERITY; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; QUALITY OF LIFE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84855165821     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/S1262-3636(11)70964-8     Document Type: Article

References (45)

1. Pickup J.C., Keen H., Parsons J.A., Alberti K.G.M.M. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1978, 1:204-207.
2. J.O n° 268 du 19 novembre 2000, page 18410. http://www.legifrance.gouv.fr/.
3. Hanaire H., Lassmann-Vague V., Jeandidier N., Renard E., Tubiana-Rufi N., Vambergue A., et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008, 34:401-423.
4. Chantelau E., Spraul M., Muhlhauser I., Gause R., Berger M. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 1989, 32:421-426.
5. Helve E., Koivisto V.A., Lehtonen A., Pelkonen R., Huttunen J.K., Nikkilä E.A. A crossover comparison of continuous insulin infusion and conventional injection treatment of Type I diabetes. Acta Med Scand 1987, 221:385-393.
6. Mecklenburg R.S., Benson J.W., Becker N.M., Brazel P.L., Fredlund P.N., Metz R.J., et al. Clinical use of the insulin infusion pump in 100 patients with type I diabetes. N Engl J Med 1982, 26:513-518.
7. Ronn B., Mathiesen E.R., Vang L., Lørup B., Deckert T. Evaluation of insulin pump treatment under routine conditions. Diabetes Res Clin Pract 1987, 3:191-196.
8. The Diabetes Control and Complication Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complication Trial. Diabetes Care 1995;18:361-76.
9. Pickup J., Mattock M., Kerry S. Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Br Med J 2002, 324:705-708.
10. Weissberg-Benchell J., Antisdel-Lomaglio J., Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003, 26:1079-1087.
11. Misso M.L., Egberts K.J., Page M., O'Connor D., Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010, 1. CD005103. Review.
12. Hanaire-Broutin H., Melki V., Bessières-Lacombe S., Tauber J.P. Comparison of CSII and MDI regimen using insulin Lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 2000, 23:1232-1235. The GEDEC Study Group.
13. Zinman B., Tildesley H., Chiasson J.L., Tsui E., Strack T. Insulin lispro in CSII: results of double-blind cross-over study. Diabetes 1997, 46:440-443.
14. 1c and blood glucose stability in IDDM patients treated with Lispro insulin analog in external pumps. Diabetes Care 1998, 21:977-982.
15. Renner R., Pfützner A., Trautmann M., Harzer O., Sauter K., Landgraf R. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care 1999, 22:784-788.
16. Colquitt J., Royle G., Waugh N. Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet Med 2003, 20:863-866.
17. DeVries J.H., Snoek F.J., Kostense P.J., Masurel N., Heine R.J. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002, 25:2074-2080. Dutch Insulin Pump Study Group.
18. Tsui E., Barnie A., Ross L., Parkes R., Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 2001, 24:1722-1727.
19. Retnakaran R., Hochman J., DeVries J.H., Hanaire-Broutin H., Heine R.J., Melki V., et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004, 27:2590-2596.
20. Retnakaran R., DeVries J.H., Hanaire-Broutin H., Heine R.J., Melki V., Zinman B. Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c. Diabetes Care 2005, 28:1835-1836.
21. Bode B.W., Steed R.D., Davidson P.C. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996, 19:324-327.
22. Pickup J.C., Sutton A.J. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections versus continuous subcutaneous insulin infusion. Diabetic Med 2008, 25:765-774.
23. Pickup J.C., Kidd J., Burmiston S., Yemane N. Determinants of glycemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006, 22:232-237.
24. Bruttomesso D., Crazzolara D., Maran A., Costa S., Dal Pos M., Girelli A., et al. In type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008, 25:326-332.
25. Bolli G.B., Capani F., Home P.D. Comparison of a multiple daily injection daily with once-daily insulin glargine basal insulin and mealtime lispro, to continuous subcutaneous insulin infusion: a randomised, open, parallel study. Diabetes 2004, 53(Suppl 2):A107-A108.
26. Doyle (Boland) E.A., Weinzimer S.A., Steffen A.T., Ahern J.A.H., Vincent M., Tamborlane W.V. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004, 27:1554-1558.
27. Hirsch I.B., Bode B.W., Garg S., Lane W.S., Sussman A., Hu P., et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005, 28:533-538.
28. Alemzadeh R., Ellis J.N., Holzum M.K., Parton E.A., Wyatt D.T. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004, 114:91-95.
29. Schiaffini R., Ciampalini P., Spera S., Cappa M., Crino A. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev 2005, 21:347-352.
30. Lepore G., Dodesini A.R., Nosari I., Trevisan R. Effect of continuous subcutaneous insulin infusion vs multiple daily injection with glargine as basal insulin; an open parallel long-term study. Diabetes Nutr Metab 2004, 17:84-89.
31. Pickup J.C., Kidd J., Burmiston S., Yemane N. Determinants of glycemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006, 22:232-237.
32. Linkeschova R., Raoul M., Bott U., Berger M., Spraul M. Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002, 19:746-751.
33. McMahon S.K., Airey F.L., Marangou D.A., McElwee K.J., Carne C.L., Clarey A.J., et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med 2004, 22:92-96.
34. Muller-Godeffroy E., Treichel S., Wagner V.M. Investigation of quality of lifeand family burden issues during insulin pump therapy in children with type 1diabetes mellitus - a large scale multicentre pilot study. Diabet Med 2009, 26:493-501.
35. Jeitler K., Horvath K., Berghold A., Gratzer T.W., Neeser K., Pieber T.R., et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008, 51:941-951.
36. Pickup J., Renard E. Long acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008, 31:S140-S145.
37. Nielsen S., Kain D., Szudzik E., Garg R., Dandona P. Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabet Educ 2005, 31:843-848.
38. Pouwels M.J., Tack C.J., Hermust A.R., Lutterman J.A. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant type 2 diabetic patients. Diabetic Med 2003, 20:76-79.
39. Wainstein J., Metzger M., Wexler I.D., Cohen J., Raz I. The use of continuous insulin delivery systems in severely insulin-resistant patients. Diabetes Care 2001, 24:1299.
40. Raskin P., Bode B.W., Marks J.B., Hirsch I.B., Weinstein R.L., McGill J.B., et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes. Diabetes Care 2003, 26:2598-2603.
41. Herman W.H., Ilag L.L., Johnson S.L., Martin C.L., Sinding J., Al Harthi A., et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005, 28:1568-1573.
42. Wainstein J., Metzeger M., Boaz M., Minuchin O., Cohen Y., Yaffe A., et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 2005, 22:1037-1046.
43. Berthe E., Lireux B., Coffin C., Goulet-Salmon B., Houlbert D., Boutreux S., et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res 2007, 39:224-229.
44. Reznik Y., Morera J., Rod A., Coffin C., Rousseau E., Lireux B., et al. Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: a survey of a cohort of 102 patients with prolonged follow up. Diabetes Technol Therap 2010, 12:931-936.
45. Labrousse-Lhermine F., Cazal L., Ruidavets J.B., Hanaire H. Long-term treatment combining subcutaneous insulin with oral hypoglycemic agents is effective in type 2 diabetes. Diabet Metab 2007, 33:253-260. The Gedec study group.